follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      Home2022June

      Month: June 2022

      Cronos Group and Geocann Work Together to Use VESIsorb® Delivery Technology
      Tech

      Cronos Group and Geocann Work Together to Use VESIsorb® Delivery Technology for Quicker Absorption

      Jun 27 Peter Olaoluwapo
      In collaboration with Geocann, Cronos Group Inc. is happy to announce the release of the first of what is anticipated to be several products that will make use of the cutting-edge VESIsorb® delivery system. Faster ... [Read]
      Agrify Enters the Lucrative New Zealand Cannabis Market With End-To-End Solutions for Cultivation and Extraction
      Cannabis

      Agrify Enters the Lucrative New Zealand Cannabis Market With End-To-End Solutions for Cultivation and Extraction Through Sales and SAAS Licensing Agreement With Ora Pharm.

      Jun 27 Peter Olaoluwapo
      AgrifyTM Corporation, the most cutting-edge supplier of advanced cultivation and extraction solutions for the cannabis industry, announced it has signed a legally binding agreement (the “Agreement”) to provide Ora Pharm, a Waikato, New Zealand-based health ... [Read]
      Amryt to Pursue Formal Dispute Resolution for Oleogel-S10 NDA
      Biotechnology

      Amryt to Pursue Formal Dispute Resolution for Oleogel-S10 (Filsuvez®) NDA

      Jun 24 Peter Olaoluwapo
      Amryt (Nasdaq: AMYT), a multinational, commercial-stage biopharmaceutical company with a focus on acquiring, developing, and commercializing novel treatments for rare diseases, today announced its intention to submit a Formal Dispute Resolution Request (FDRR) for its ... [Read]
      Eton Pharmaceuticals Sells Hospital Supplies to Dr. Reddy
      Biotechnology

      Eton Pharmaceuticals Sells Hospital Supplies to Dr. Reddy’s for up to $50M

      Jun 24 Peter Olaoluwapo
      Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today declared that it had agreed to sell its hospital goods to Dr. Reddy’s Laboratories SA, a ... [Read]
      Splash Beverage Group
      Beverages

      Splash Beverage Group Enters into Agreement to Purchase 80% of Pulpoloco Sangria

      Jun 23 Peter Olaoluwapo
      Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of well-known beverage brands, announced today that it has signed a contract to purchase 80 percent of Pulpoloco Sangria. As a ... [Read]
      Evaxion Biotech Broadens EVX-03 DNA Vaccine Project
      Biotechnology

      Evaxion Biotech Broadens EVX-03 DNA Vaccine Project Into Non-Small Cell Lung Cancer.

      Jun 23 Peter Olaoluwapo
      Evaxion Biotech A/S (NASDAQ: EVAX) a clinical-stage biotechnology company focused on the creation of AI-driven immunotherapies, announced today that it has chosen EVX-03 as the product candidate within its DNA technology platform to target a ... [Read]
      Biotechnology

      Optimi Health Requests for Authorization to Manufacture MDMA, Other Synthetic Psychedelics

      Jun 22 Peter Olaoluwapo
      Optimi Health Corp, a native Canadian business that creates natural, scalable, and affordable mushroom formulations for transformational human experiences, has made a health request to Canada for an amendment to the Controlled Substances Dealer’s Licence. ... [Read]
      Massage Envy Enhances Massage and Skin Care Portfolio With CBD Offerings
      Cannabis

      Massage Envy Enhances Massage and Skin Care Portfolio With CBD Offerings From Charlotte’s Web, The World’s Most Reliable Hemp Extract™ (CWBHF)

      Jun 22 Peter Olaoluwapo
      Massage Envy, the nation’s No. 1 provider of massage in the U.S. overall across its franchise network and a national leader in skincare, together with Charlotte’s Web Inc., the market leader in creating next-generation, hemp-derived ... [Read]
      Consumer

      TAAT Global Alternatives Has Appointed Michael Saxon as CEO

      Jun 21 Peter Olaoluwapo
      TAAT Global Alternatives Inc. (CSE:TAAT) recently announced the appointment of Michael Saxon as Chief Executive Officer. Saxon will also be joining as a member of its Board of Directors.  Michael Saxon is a 20-year global ... [Read]
      FPX Nickel Signs a Development Memorandum of Agreement
      Metals & Mining

      FPX Nickel Signs a Development Memorandum of Agreement with Indigenous Partner Binche Whut’en

      Jun 21 Peter Olaoluwapo
      FPX Nickel Corp. (TSXV:FPX) is pleased to announce that it has signed a new Development Memorandum of Agreement (“MoA”) with the Binche Keyoh Bu Society (the “Binche Society”), which represents the Keyoh families within the ... [Read]

      Posts pagination

      1 2 3 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2025 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2025 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Subscribe & Get The LATEST Stock Pick Alerts
      Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      x